| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.007 |